ETF DAILY NEWS

Analysts Set TransMedics Group, Inc. (NASDAQ:TMDX) PT at $122.70

Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eleven brokerages that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong […]

Mar 12, 2025 - 06:52
 0
Analysts Set TransMedics Group, Inc. (NASDAQ:TMDX) PT at $122.70
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eleven brokerages that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong […]
Read More

Tags:

Previous Article

Gain Therapeutics, Inc. (NASDAQ:GANX) Receives $8.20 Consensus Price Target from...

Next Article

Analysts Set DoorDash, Inc. (NASDAQ:DASH) Target Price at $206.52

Related Posts

Guild Holdings (NYSE:GHLD) Receives $16.67 Average Target Price from Analysts

Guild Holdings (NYSE:GHLD) Receives $16.67 Average Targ...

Feb 18, 2025  0

Comparing Coca-Cola HBC (OTCMKTS:CCHGY) & Primo Brands (NYSE:PRMB)

Comparing Coca-Cola HBC (OTCMKTS:CCHGY) & Primo Brands ...

Mar 1, 2025  0

Allspring Global Investments Holdings LLC Raises Stake in Constellation Brands, Inc. (NYSE:STZ)

Allspring Global Investments Holdings LLC Raises Stake ...

Feb 21, 2025  0